Surreal illustration of vitamin D, heart health, and metabolic balance

Vitamin D and Your Heart: Is There a Connection?

"Emerging research explores the link between Vitamin D deficiency and heart health, particularly for those with metabolic syndrome."


Vitamin D, often called the "sunshine vitamin," is critical for bone health and calcium balance. But recent research suggests its role extends far beyond this, influencing various aspects of our health, including cardiovascular well-being. Studies have shown that low levels of vitamin D may be associated with increased risk factors for heart disease, especially in people with metabolic syndrome.

Metabolic syndrome (MetS) is a cluster of conditions that occur together, increasing the risk of heart disease, stroke, and type 2 diabetes. These conditions include increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol levels. Individuals with MetS are particularly vulnerable to the adverse effects of vitamin D deficiency.

This article will explore the findings of a recent study investigating the relationship between vitamin D levels and non-traditional risk factors for cardiovascular disease in subjects with metabolic syndrome. We'll break down the key findings and discuss what they mean for your health.

The Vitamin D and Metabolic Syndrome Connection: What the Research Reveals

Surreal illustration of vitamin D, heart health, and metabolic balance

A study published in Archives of Medical Science investigated the connection between vitamin D and cardiovascular risk factors in 110 individuals, some diagnosed with metabolic syndrome (MetS) and others without. The research team sought to determine if there was a relationship between vitamin D levels and emerging risk factors associated with MetS, such as small dense low-density lipoprotein cholesterol (sdLDL-C) concentration, lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, and high-sensitivity C-reactive protein (hsCRP) levels.

Here's a summary of the main findings:

  • Lower Vitamin D Levels in MetS: Individuals with metabolic syndrome had significantly lower vitamin D levels compared to those without MetS.
  • Inverse Relationship with Triglycerides and sdLDL-C: In subjects with MetS, vitamin D concentration was inversely related to triglycerides and sdLDL-C levels. This suggests that lower vitamin D levels might contribute to higher levels of these harmful substances.
  • No Direct Association with Lp-PLA2 or hsCRP: The study did not find a direct link between vitamin D levels and Lp-PLA2 activity or hsCRP levels, two markers of inflammation.
AI Search Multiple angles on this topic

Vitamin D and Cardiometabolic Research

A study on suspected metabolic syndrome cases describes vitamin D as having a potential role in glucose homeostasis and insulin regulation, while noting that hypovitaminosis D has been increasing worldwide, especially in Asian countries. Another study in adolescent girls reported that vitamin D levels were not associated with hsCRP, a marker of chronic inflammation and cardiovascular risk. Research in overweight and obese females suggests that higher vitamin D-binding protein may reduce free and bioavailable 25(OH)D. A 2025 narrative review argues that vitamin D’s potential effects on inflammation, oxidative stress, endothelial function, and cardiometabolic risk factors support considering it within a broader cardiovascular-health approach.

Limits and Uncertainty in the Evidence

A study of people with metabolic syndrome notes that its cross-sectional design could not establish whether vitamin D caused changes in emerging cardiovascular risk factors. A 2024 JACC: Advances commentary describes a 10-year follow-up of the Nova Scotia Health Survey concerning vitamin D deficiency and ischemic heart disease among people with established cardiovascular disease. Separately, an analysis of the Emory Cardiovascular Biobank reported an association between vitamin D deficiency and higher risks of major adverse cardiovascular events and mortality, using a threshold below 20 ng/dL. These findings report associations, while the cited cross-sectional study specifically cautions that it cannot establish causation.

The researchers concluded that people with metabolic syndrome often exhibit lower vitamin D levels. Low vitamin D is associated with higher sdLDL-C levels, potentially mediated through elevated triglycerides. However, the study found no association between vitamin D and Lp-PLA2 or hsCRP.

What Does This Mean for You? The Takeaways

This study adds to the growing body of evidence suggesting a link between vitamin D deficiency and increased cardiovascular risk, particularly in individuals with metabolic syndrome. Maintaining optimal vitamin D levels may be a crucial component of heart health, especially if you have MetS.

AI Search Multiple angles on this topic

A Broad but Inconsistent Research Picture

A 2024 study notes that prior research has suggested a possible link between vitamin D deficiency and adverse cardiovascular outcomes, but that findings have been inconsistent. It examines the association in the context of established cardiovascular risk factors. A 2025 review reports that vitamin D receptors are expressed in many tissues and describes correlations between deficiency and coronary artery disease and hypertension. Together, these sources point to ongoing interest in the relationship while emphasizing that reported findings include inconsistency and correlations.

Testing Tailored Vitamin D Monitoring

A report on the American Heart Association Scientific Sessions 2025 describes a study in adults with heart disease who received vitamin D doses tailored to reach blood levels considered optimal for heart health, defined as greater than 40–80 ng/mL. Those receiving tailored doses had a reported 52% lower risk of heart attack than adults who did not receive vitamin D-level monitoring. The report identifies the finding as Abstract 4382525. This result offers a specific direction for further research into monitored, individualized dosing, but the provided source describes a conference abstract rather than establishing a general treatment recommendation.

Different Estimates in Real-World Studies

A 2025 real-world study found substantially weaker associations between vitamin D deficiency or insufficiency and atherosclerotic cardiovascular disease diagnoses in its main model than those reported in prior cohort-study meta-analyses. For ischemic heart disease, it reported a 10% increased risk associated with deficiency, compared with 39% in the meta-analysis. A study in Iraq examined the association between vitamin D deficiency and acute myocardial infarction, while noting that the connection between deficiency and coronary artery disease is controversial. Another study in participants with stable coronary heart disease found vitamin D deficiency associated with cardiovascular events after accounting for sociodemographic factors, comorbidities, and health behaviors.

However, it's essential to remember that this study reveals associations, not causation. Further research is needed to determine if vitamin D supplementation can directly reduce cardiovascular risk factors and improve heart health outcomes.

If you are concerned about your vitamin D levels or have risk factors for heart disease, talk to your doctor. They can assess your vitamin D status and recommend appropriate strategies to optimize your health.

What a cross-sectional comparison can establish

Observational study (level 4 of 8)

This observational, cross-sectional study can describe how vitamin D levels and measured risk factors occurred together, but it cannot show that one caused changes in the other. The sample included otherwise healthy participants with metabolic syndrome and controls, so its findings describe this group rather than proving a broader effect.[1] [2]

Vitamin D levels compared between groups

  • 11.8 vs 17.2 ng/mlThe median vitamin D level was 11.8 ng/ml in the metabolic-syndrome group, compared with 17.2 ng/ml in controls; the difference between groups was statistically significant (p = 0.027).[2]Caveat: p = 0.027

What the risk-factor pattern does and does not show

Within the metabolic-syndrome group, lower vitamin D tracked with higher triglycerides and small dense LDL cholesterol. But when triglycerides were included in the adjusted analysis, vitamin D no longer independently explained the small dense LDL relationship; this is consistent with triglycerides being the stronger statistical link, not proof of a pathway.[1] [2]

The study did not find significant relationships with LDL particle size, Lp-PLA2, or hsCRP. Taken together, the findings point to a selective association with some lipid measures rather than a consistent relationship across all measured markers.[1]

A comparison of metabolic-syndrome participants and controls

Study designObservational study[2]
PopulationOtherwise healthy individuals, including subjects with metabolic syndrome and controls who did not meet MetS criteria[2]
Sample size110 (52 with MetS and 58 controls)[2]
Comparison58 individuals who did not meet the MetS criteria[2]
Main outcomeRelationship between 25(OH)Vit D and emerging CVD risk factors in subjects with MetS[2]
Effect sizeMetS subjects had lower 25(OH)Vit D levels than controls; 11.8 vs 17.2 ng/ml[2]
p-valuep = 0.027 for difference in 25(OH)Vit D levels between groups[2]
Times cited37[2]

How this result fits with related evidence

The paper situates its findings within earlier reports linking vitamin D with triglycerides and HDL cholesterol, while a large European cohort also reported an inverse association with triglycerides after adjustment for several factors. These comparisons provide context, not confirmation that vitamin D causes lipid changes.[1]

What a follow-up study would need to clarify

  • Would repeated measurements show that vitamin D changes occur before changes in triglycerides or small dense LDL, rather than simply accompanying them?[1] [2]
  • Would the relationships remain when other factors that can accompany vitamin D status and metabolic health are accounted for?[1] [3]

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.5114/aoms.2012.29398, Alternate LINK

Title: The Relationship Of Vitamin D With Non-Traditional Risk Factors For Cardiovascular Disease In Subjects With Metabolic Syndrome

Subject: General Medicine

Journal: Archives of Medical Science

Publisher: Termedia Sp. z.o.o.

Authors: Stefania Makariou, Evangelos Liberopoulos, Matilda Florentin, Konstantinos Lagos, Irene Gazi, Anna Challa, Moses Elisaf

Published: 2012-01-01

Everything You Need To Know

1

What is Vitamin D and why is it important?

Vitamin D, often referred to as the "sunshine vitamin," is essential for maintaining bone health and calcium balance. However, current research suggests its importance extends beyond these roles, impacting multiple aspects of overall health, including cardiovascular well-being. Studies have explored the link between low levels of Vitamin D and increased cardiovascular risk factors, particularly for those with Metabolic Syndrome.

2

What is Metabolic Syndrome and how is it related to the study's findings?

Metabolic Syndrome (MetS) is a combination of health issues, including high blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol levels. These conditions together significantly raise the risk of heart disease, stroke, and type 2 diabetes. The article highlights that individuals with MetS are particularly vulnerable to the adverse effects of Vitamin D deficiency. The study investigated the connection between Vitamin D levels and several cardiovascular risk factors in individuals with and without MetS.

3

What were the main findings of the study?

The findings of the study suggest that individuals diagnosed with Metabolic Syndrome (MetS) tend to have significantly lower Vitamin D levels compared to those without MetS. Furthermore, the study revealed an inverse relationship between Vitamin D concentration and Triglyceride and sdLDL-C levels in subjects with MetS. This suggests that lower Vitamin D levels might contribute to higher levels of these harmful substances. However, the research found no direct association between Vitamin D levels and Lp-PLA2 activity or hsCRP levels.

4

What is sdLDL-C, and what role did it play in this research?

sdLDL-C, or small dense low-density lipoprotein cholesterol, is a type of cholesterol associated with an increased risk of heart disease. The study indicated an inverse relationship between Vitamin D levels and sdLDL-C concentration in individuals with Metabolic Syndrome (MetS). This suggests that lower Vitamin D levels may contribute to higher sdLDL-C levels, which could increase the risk of cardiovascular issues.

5

What are the key takeaways from the research?

This study reinforces the growing body of evidence linking Vitamin D deficiency to increased cardiovascular risk, especially among those with Metabolic Syndrome (MetS). The research highlights that maintaining sufficient Vitamin D levels might be a crucial element of heart health. While this study offers valuable insights, it also underscores the need for more comprehensive research to fully understand the relationship between Vitamin D and heart health. Further research should explore potential implications for public health recommendations and personalized medicine strategies.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.